Etoposide: fifteen years experience.
Bernasconi
C
C
Divisione di Ematologia, Policlinico San Matteo IRCCS, Pavia, Italy.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy; D008130:Lomustine / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage; D008942:Mitoxantrone / Q000008:administration & dosage
D003561:Cytarabine; D005047:Etoposide; D008130:Lomustine; D008942:Mitoxantrone; D008558:Melphalan